Q: Thoughts on SBRA?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Gilead Sciences Inc. (GILD $117.18)
-
Intuitive Surgical Inc. (ISRG $429.59)
-
AbbVie Inc. (ABBV $230.50)
-
Johnson & Johnson (JNJ $190.72)
-
Eli Lilly and Company (LLY $833.49)
-
Medtronic plc. (MDT $95.45)
-
Stryker Corporation (SYK $364.60)
-
Thermo Fisher Scientific Inc (TMO $524.80)
-
Health Care Select Sector SPDR (XLV $142.11)
-
iShares U.S. Medical Devices ETF (IHI $58.83)
-
Sabra Health Care REIT Inc. (SBRA $17.74)
-
Healthcare Realty Trust Incorporated (HR $17.90)
-
iShares U.S. Pharmaceuticals ETF (IHE $74.04)
-
Catalyst Pharmaceuticals Inc. (CPRX $20.36)
Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.
Q: Hi, what do you think of Sabra Healthcare REIT (SBRA) for aging US population? How does it compare to CSH and Sienna in Canada? Is timing OK with forecasted 3 rate changes in US this year? Other better suggestions for aging US population?